Dianthus Therapeutics Funding: $100M Raised, Series A (2022)

Dianthus Therapeutics is based in New York, NY. It has raised $100M in total funding. Latest round: Series A.

Dianthus Therapeutics funding overview

Dianthus Therapeutics is based in New York, NY. Dianthus Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2022. The round record for Dianthus Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include 5AM Ventures, Avidity Partners, Fidelity Management & Research Company, Wedbush Healthcare Partners, Fairmount, Tellus BioVentures and 1 others. 7 distinct backers are named across the disclosed rounds.

Dianthus Therapeutics at a glance

Total raised
$100M
Latest round
Series A
Latest round date
May 2022
Headquarters
New York, NY
Notable investors
5AM Ventures, Avidity Partners, Fidelity Management & Research Company, Wedbush Healthcare Partners, Fairmount, Tellus BioVentures, Venrock Healthcare Capital Partners

Frequently asked about Dianthus Therapeutics funding

How much has Dianthus Therapeutics raised?
Dianthus Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Dianthus Therapeutics?
5AM Ventures, Avidity Partners, Fidelity Management & Research Company, Wedbush Healthcare Partners, Fairmount, Tellus BioVentures are named among the investors backing Dianthus Therapeutics.
What was the latest Dianthus Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2022.
Where is Dianthus Therapeutics based?
Dianthus Therapeutics is based in New York, NY.
When did Dianthus Therapeutics last raise?
The last disclosed Dianthus Therapeutics round closed in May 2022 at Series A.

Round data for Dianthus Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.

Companies related to Dianthus Therapeutics (36)

Browse related funding lists (9)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades